Author Guidelines
1. Language
Only manuscripts written in English are acceptable for publication, if English is author's second language, we recommend that the paper be proofread to ensure its accuracy and improve the language quality. Neoplasia Research also offers language editing services, on payment.
2. Article Length
The number of pages of the article is at the discretion of authors; on an average, articles should be 10-23 pages long including the references. The Editors generally encourage brevity, yet providing the sufficient details, for all articles. Short Communications must not exceed 6 printed pages; and will be given priority for rapid publication.
3. Title
The title should be concise and informative and avoid abbreviations and formulae. Omit the words such as “New”; and “Novel,” and should describe the goal, the concept, or new findings other than the approach or method, except it is in the category of TECHNOLOGY, METHOD, AND COMMERCIALIZATION. The wording of “Research on”, “Study on”, “Analysis for”, “testing of” “Investigations of,” and “Observations of” should be avoided.
4. Corresponding author.
For the manuscripts authored by more than one author, the corresponding author’s name should be marked with an asterisk and his/her email address must be provided in the footnote.
He/she may also be mentioned as “Please send correspondence to name………. at Email………..”.
Change of address and current address.
If an author has moved after the work in the manuscript was completed, 'Current address' should be indicated as foot note. The address where the author did the work must be retained as the affiliation.
5. Abstract
The abstract should be brief, including why, how, and what, that is, why you carried out this research, how you carried out the research, and what is the major finding and conclusion. The abstract is an independent and stand-alone short article as a summary of the entire manuscript. It should be free from any subheading and references or unexplained abbreviations. As many electronic databases scan only the title and abstract of the articles, it will be beneficial if as many likely key words of the articles are used in the text of the abstract as possible. For word limit of Abstract, see Types of Articles.
6. Keywords
Immediately after the abstract, please provide up to seven keywords for indexing purposes. The keywords should not be too broad, too general (common), and should not be multiple concepts of plural terms. The phases in the title will not need to state as keywords. In case of abbreviations, only those firmly established in the field may be eligible as keywords.
7. Abbreviations
Provide a list of abbreviations defined at the bottom of the first page. All Abbreviations present in the manuscriptshould be listed.
8. Structure of text
For Letter of Communications, review articles and Original Research Articles, the text should include the headings. See Types of Articles.
9. Units
Only SI units should be used. If other units are necessary, include the conversion factor and add the non-standard unit in parenthesis.
10. Symbols
All symbols should be defined in text. If there is an extensive list of symbols, place it in the appendix at the end of the manuscript.
11. Math
In case of mathematical numbers’ presentation, punctuate carefully.
12. Footnotes
If foot notes are required in the manuscript, these should be identified by superscript Arabic numbers. Table footnotes should be mentioned with superscript small case English alphabets.
13. Illustrations
- All illustrations should be provided in the camera-ready form, suitable for reproduction (which may include reduction) without retouching.
- All illustrations must be readable when reduced to a width of 75 mm (single column figure) or 160 mm (double column figure).
- Regardless of the application used, when your electronic artwork is finalized, please save as, or convert the images to .tiff or .jpg formats.
- Photographs, charts, and diagrams are all to be referred to as "Figure(s)" and should be numbered consecutively to which they are referred. They should accompany the manuscript either in the end of the article or as separate files. If deemed necessary, figures may also be embedded in the text by the author.
- Figures artwork must have a minimum resolution of 300dpi. Each figure should be designed in the consideration of 1) parallel, 2) symmetry, 3) contrast, and 4) alignment.
- All illustrations should be clearly numbered according to their sequencing order in the text.
- Each figure will include a Figure Legend with a Caption. A caption is a summary/title of the entire figure. The legend should not include results, but only the explanation of the drawings and the words in the figures to let the reader understand what the symbols, colors, and abbreviations in the figures mean. That is to facilitate the reader's understanding of what each part of the figure means. The results and findings will be described in the text, but not in the figure legends.
- If text is needed to be embedded in the illustrations, it should be kept at a minimum but, explained in the figure legend. The size relationship between drawings and words should be “the words will be as large as possible while the drawing will be as small as it can be visible.
14. Tables
Tables should be numbered consecutively as they are cited in the text. These should be clearly arranged, and each column of the table should bear a heading Footnotes to tables should be present below the tables and should be referred to by superscript lowercase letters. All arithmetic (percentages, totals, differences) should be accurate. Any abbreviation used in the table must be explained in the footnote. Tables should not duplicate result presented elsewhere in the manuscript (e.g., in the graph).
15. Author's Contribution
If more than one author authors the article, the individual contribution of each co-author must be mentioned under this heading.
16. Acknowledgements
An expression of appreciation may be paid to supporters who do not meet the criteria for authorship but have helped the researchers in any other form (technical help, writing of manuscript etc.).
17. References
References must be listed in the numerical system (Vancouver style). All references should be numbered sequentially (in square brackets, […]) as they appear for the first time in the text and listed in the same numerical order in the reference section. Bibliographies cited in tables and figures should be numbered according to the site where the corresponding table or figure is first referenced. The reference numbers must be finalized, and the bibliography must be fully formatted before submission.
In the case of four or more co-authors, the names of the first three authors should be listed followed by et. al:
Journal titles should be abbreviated. (to decipher abbreviations see: PubMed Journals Database <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=journals>)
Important points to remember:
- All references must be complete and accurate.
- If the number of authors exceeds three, then "et al." will be used after three names (the term "et al." should be in italics).
- Online citations should include the date of access.
- Journal abbreviations should follow the Index Medicus/MEDLINE.
- Take special care of the punctuation convention as described in the examples mentioned below.
- Avoid using superscript in the in-text citations and reference section.
- Abstracts, unpublished data, and personal communications (which can only be included if prior permission has been obtained) should not be given in the reference section, but they may be mentioned in the text and details should be provided as footnotes.
- The authors are encouraged to use a recent version of EndNote (version 5 and above) or Reference Manager (version 10) when formatting their reference list, as this allows references to be automatically extracted.
See below some examples of references listed in the correct Vancouver style:
Journal articles:
[1] Smith SD, Jones, AD. Organ donation. N Engl J Med 2001; 657: 230-5.
[2] Brown JG. Asphyxiation. Med J Aust 2003; 432:120-4.
Typical Chapter Reference:
[3] Blaxter PS, Farnsworth TP. Social health and class inequalities. In: Carter C, Peel JR, editors. Equalities and inequalities in health. 2nd ed. London: Academic Press 1976; p. 165-78.
Book Reference:
[4] Carlson BM. Human embryology and developmental biology. 3rd ed. St. Louis: Mosby; 2004.
Edited Book:
[5] Brown AM, Stubbs DW, Eds. Medical physiology. New York: Wiley 1983.
Conference Paper and Proceedings:
[6] Anderson JC. Current status of chorion villus biopsy. In: Tudenhope D, Chenoweth J, editors. Proceedings of the 4th Congress of the Australian Perinatal Society; 1986: Brisbane, Queensland: Australian Perinatal Society; 1987: p. 190-6.
[7] Harris AH, editor. Economics and health: 1997: Proceedings of the 19th Australian Conference of Health Economists; 1997: Sep 13-14; Sydney, Australia. Kensington, N.S.W.: School of Health Services Management, University of New South Wales; 1998.
Journal Article on the Internet:
[8] Aylin P, Bottle A, Jarman B, Elliott, P. Pediatric cardiac surgical mortality in England after Bristol: descriptive analysis of hospital episode statistics 1991-2002. BMJ [serial on the Internet]. 2004 Oct 9; [cited 2004 October 15]; 329: [about 10 screens]. Available from: http://bmj.bmjjournals.com/cgi/content/full/329/7470/825
Book/Monograph on the Internet:
[9] Donaldson MS, editor. Measuring the quality of health care [monograph on the Internet]. Washington: National Academy Press; 1999 [cited 2004 Oct 8]: Available from http://legacy.netlibrary.com/
Web site/Homepage:
[10] HeartCentreOnline [homepage on the Internet]. Boca Raton, FL: HeartCentreOnline, Inc.; c2000-2004 [updated 2004 May 23; cited 2004 Oct 15]: Available from: http://www.heartcenteronline.com/
Journal with Part/Supplement:
If a journal carries continuous pagination throughout the volume, then the issue number can be omitted.
Issue with Supplement:
[11] Glauser TA. Integrating clinical trial data into clinical practice. Neurology 2002; 58(12 Suppl 7): S6-12.
Volume with Part:
[12] Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal 2002; 83(Pt 2): 491-5.
Issue with Part:
[13] Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol 2002; 13(9 Pt 1): 923-8.
Patent:
[14] Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug.
E-citations:
[15] Citations for articles/material published exclusively online or in open access (free-to-view) must contain the exact Web addresses (URLs) at the end of the reference(s), except those posted on an author's Web site unless editorially essential, e.g., 'Reference: Available from: URL'.
18. Supplementary material
Supplementary material will be published exactly as the author provided. Please accept all tracked changes and switch off the 'Track Changes' option in Microsoft Office files to avoid the appearance of the published version.
19. Conflict of interest statement
Each article should include a section of Conflict of Interest.
In its Guidelines on Good Publication Practice (2018), the Committee on Publication Ethics (COPE) states that:
‘A conflict of interest is something that if undeclared but discovered later would make a reasonable reader feel misled or deceived. Conflicts of interest are situations that have the potential to influence people’s judgements. Such situations may affect, or may be perceived to affect, every stage of research, from planning to applying for or allocating funding, conducting a study, interpreting data and reporting research.’
A conflict of interest can occur when authors, or their employer, or sponsor have a financial, commercial, legal, or professional relationship with other organizations, or with people in a working relationship with them, that could excessively influence, or may be perceived to influence, at any stage of the research.
The corresponding author is responsible to provide a declaration of conflict of interest/ competing interest on behalf of all co-authors. The author should disclose any existing, potential, or perceived Conflict of Interest with any commercial associations of current and within the last five years as defined by NIH or general academic institutes.
However, the details of financial arrangements are not required to be disclosed if a conflict of interest is declared in the article.
Such a declaration should be stated at the end of your manuscript after any Acknowledgements, if present, and prior to the Funding statement and References, under the heading 'Declaration of Conflicting Interest'.
A statement is also required when there is no conflict of interest at all. In such situations, please use the below wordings;
'The Author(s) declare(s) that there are no relevant financial or non-financial competing interests to report.’
Please note that the declaration of the presence of some conflict of interest will not affect the fair evaluation of such articles and these will not necessarily be rejected.
Few examples of financial conflicts of interests include, but are not limited to:
- Employment or voluntary involvement in a related company
- Receiving funds for consulting or research
- Receiving grants from a body, paid to the author or organization.
- Personal fees received by the authors as honoraria, royalties, consulting fees, lecture fees, or testimonies.
- Royalties being received by the authors or their institutions.
- Stock or shares holding in a company that may be financially affected by this publication.
- Receiving a reimbursement for attending symposia/talk/conference related to your research article.
- Benefits related to the development of products as an outcome of the work.
Some Examples of non-financial conflicts of interests:
- receiving drugs, specialist equipment, tools, computer programs, or digital applications
- Access to data repositories, archival resources, museum collections, by an entity that might get benefitted, or be at a financial/reputational loss from the published findings.
- Being a member of the boards of industry bodies or private companies that might benefit or be at a disadvantage financially or reputationally from the published findings.
- Writing assistance or administrative support from a person or organization that might benefit or be at a disadvantage from the published findings.
- Personal, political, religious, ideological, academic, and intellectual competing interests which are perceived to be relevant to the published content.
- Involvement in legal action related to the work.
Please note the above lists are not the exhaustive ones.
20. Funding Statement
Authors should acknowledge all funding sources (institutional, private, and corporate financial support) that supported their work. This information should contain the name of the funding organization(s) and the grant number, mentioned at the end of the article under the heading ‘FUNDING’, directly after the Acknowledgements (if applicable) and Declaration of Conflicting Interests, and prior to the References. The funding agency should be written out in full, followed by the grant number in square brackets, e.g.,
This work was supported by the Medical Research Council [grant number xxx].
If there was no funding, the following wording should be used:
“This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.”
Any suppliers of materials should be named, and their location (town, state/county, country) included in the section of MATERIAL and METHODS.
Multiple grant numbers should be separated by comma and space. If the research was supported by more than one agency, the different agencies should be separated by semi-colon, with “and” before the final funder, e.g.:
This work was supported by the Foundation [grant numbers aaaa, bbbb]; the Environmental Research Council [grant number cccc]; and the Economic Development Research Council [grant number zzzz].
Indirect funding, if received, must also be declared in the funding statement. Indirect funding includes third-party entities receiving funding from any industry, where the funder could be seen to have a vested interest in the results of a study.